St. Jude Medical Inc.

Jefferies provided color on Volcano Corporation (NASDAQ: VOLC) in a research report published today. Jefferies commented on the new lawsuit by St. Jude Medical (NYSE: STJ). In the report, Jefferies states, "STJ filed another lawsuit against VOLC in their ongoing OCT litigation. STJ now alleges...

Wedbush, citing a solid quarter on track with expectations, has raised its price target on St. Jude Medical (NYSE: STJ) from $38 to $46. According to Wedbush, “St. Jude Medical reported first quarter results that reflected strong product sales, improving gross margins, and solid execution across...

J.P. Morgan, which raised its PT on shares of St. Jude Medical Inc. (NYSE: STJ), is providing some color on the stock. “It's been nine years since a significant new product was launched in ICDs, one big enough to move more than a point or two of share,” J.P. Morgan writes. “We've seen a number of...

St. Jude Medical Inc. (NYSE: STJ) hosted an upbeat investor meeting this past Friday in New York and outlined its growth initiatives for 2011 and beyond. “The company highlighted 18 new growth platforms which management estimates address markets that in aggregate exceed $14B in potential...